Gipharmex S.p.a.

Calculating rank

USPTO Granted Patents = 4

Forward Citations = 57

Loading Chart...

6 inventors (with patents filed for the assignee):

Aldo Roda (4 out of 16 patents)

Roberto Pellicciari (3 out of 66 patents)

Giuliano Frigerio (2 out of 11 patents)

4. Virginio Castagnola (2 out of 4 patents)

5. E Giuliano Frigerio (2 out of 3 patents)

6. Enrico Roda (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 4981983 - Derivatives of biliary acids, process for the production thereof and (1991-01-01),

2. 4931038 - Complex of products for the rapid and not-invasive treatment of biliary (1990-06-05),

3. 4921848 - Biliary acid derivatives, processes for the preparation thereof and (1990-05-01),

4. 4892868 - Derivatives of biliary acids, process for the production thereof and (1990-01-09),

Company Overview

Gipharmex S.p.a. is a leading pharmaceutical company specializing in the manufacturing and distribution of high-quality generic and branded medications. With a commitment to excellence and innovation, Gipharmex strives to improve health outcomes for patients worldwide. Our state-of-the-art facilities and skilled team ensure the production of safe and effective medications that meet the highest industry standards.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#346 in Milan

#1,962 in Italy

Milan, Italy

Gipharmex S.p.a.

Forward Citations = 57

6 inventors:

Aldo Roda (4 out of 16 patents)

Roberto Pellicciari (3 out of 66 patents)

Giuliano Frigerio (2 out of 11 patents)

4. Virginio Castagnola (2 out of 4 patents)

5. E Giuliano Frigerio (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gipharmex S.p.a.. Retrieved from https://idiyas.com/company/gipharmex

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]